These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6572628)

  • 1. The cytoreceptor assay for 1,25-dihydroxyvitamin D and its application to clinical studies.
    Manolagas SC; Culler FL; Howard JE; Brickman AS; Deftos LJ
    J Clin Endocrinol Metab; 1983 Apr; 56(4):751-60. PubMed ID: 6572628
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytoreceptor assay for 1,25-dihydroxyvitamin D.
    Manolagas SC
    Methods Enzymol; 1986; 123():190-8. PubMed ID: 3010040
    [No Abstract]   [Full Text] [Related]  

  • 3. Estimation of 1,25 dihydroxyvitamin D by cytoreceptor and competitive protein binding assays without high pressure liquid chromatography.
    Nicholson GC; Kent JC; Gutteridge DH; Retallack RW
    Clin Endocrinol (Oxf); 1985 May; 22(5):597-609. PubMed ID: 2992845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies.
    Reinhardt TA; Horst RL; Orf JW; Hollis BW
    J Clin Endocrinol Metab; 1984 Jan; 58(1):91-8. PubMed ID: 6605973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the internalization of vitamin D3 metabolites by cultured osteogenic sarcoma cells and their application to a non-chromatographic cytoreceptor assay for 1,25-dihydroxyvitamin D3.
    Manolagas SC; Deftos LJ
    Biochem Biophys Res Commun; 1980 Jul; 95(2):596-602. PubMed ID: 6251814
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of vitamin D and its active form].
    Shimotsuji T; Seino Y; Sumi K; Yabuuchi H
    Nihon Rinsho; 1977 Nov; 35(11):3966-72. PubMed ID: 202764
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating concentrations of 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism.
    Thakker RV; Fraher LJ; Adami S; Karmali R; O'Riordan JL
    Bone Miner; 1986 Apr; 1(2):137-44. PubMed ID: 3508721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3.
    Halloran BP; Schaefer P; Lifschitz M; Levens M; Goldsmith RS
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1063-9. PubMed ID: 6333430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term effects of renal transplantation on the metabolism of vitamin D3.
    Saha H; Salmela K; Ahonen J; Pietilä K; Mörsky P; Pasternack A
    Transplant Proc; 1992 Feb; 24(1):367-8. PubMed ID: 1539320
    [No Abstract]   [Full Text] [Related]  

  • 10. [Levels of plasma 1,25-dihydroxyvitamin D and parameters of phospho-calcium metabolism in children with non-dialyzed chronic renal failure].
    Loras B; Parchoux B; Durr F
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():755-60. PubMed ID: 6897703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of circulating 1,25-dihydroxyvitamin D employing radioimmunoassay].
    Yamamoto I; Hamazu H; Kigami Y; Morita R
    Kaku Igaku; 1997 Apr; 34(4):243-50. PubMed ID: 9183148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
    Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
    J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal serum 1,25-dihydroxyvitamin D in patients with medullary carcinoma of the thyroid.
    Lee S; Morimoto S; Onishi T; Tsuji M; Okada Y; Seino Y; Ishida M; Yamaoka K; Takai S; Miyauchi A; Kumahara Y
    J Clin Endocrinol Metab; 1982 Aug; 55(2):361-3. PubMed ID: 6979551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An assay for circulating 1,25-dihydroxy-vitamin D employing purification with a mini-column--comparison with a method using purification by high performance liquid chromatography].
    Takada M; Yamamoto I; Onaka Y; Hamazu M; Morita R; Aoki E; Yu I
    Kaku Igaku; 1991 Jun; 28(6):659-64. PubMed ID: 1895562
    [No Abstract]   [Full Text] [Related]  

  • 15. 1,25-Dihydroxycholecalciferol as measured by a radioreceptor assay in normal subjects and patients after kidney transplantation.
    Bonnin MR; González MT; Huguet J; Rosel P; Navarro MA
    Clin Chem; 1990 Feb; 36(2):389-90. PubMed ID: 2302793
    [No Abstract]   [Full Text] [Related]  

  • 16. Validation of a radioreceptor assay for 1,25-dihydroxyvitamin D using selected ion monitoring GC-MS.
    Oftebro H; Falch JA; Holmberg I; Haug E
    Clin Chim Acta; 1988 Aug; 176(2):157-68. PubMed ID: 3180464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
    Korkor AB
    N Engl J Med; 1987 Jun; 316(25):1573-7. PubMed ID: 3035373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in technics for analysis of the blood vitamin D3 levels].
    Okano K
    Nihon Rinsho; 1982; 40(12):2644-9. PubMed ID: 6298485
    [No Abstract]   [Full Text] [Related]  

  • 19. 1,25-dihydroxyvitamin D microassay employing radioreceptor techniques.
    Reinhardt TA; Hollis BW
    Methods Enzymol; 1986; 123():176-85. PubMed ID: 3010038
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of 1 alpha-hydroxyvitamin D2 to activated dihydroxyvitamin D 2 metabolites decreases endogenous 1 alpha, 25-dihydroxyvitamin D 3 in rats and monkeys.
    Knutson JC; Hollis BW; LeVan LW; Valliere C; Gould KG; Bishop CW
    Endocrinology; 1995 Nov; 136(11):4749-53. PubMed ID: 7588202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.